Rezolute said on Thursday its therapy aimed at controlling excessive insulin activity in patients with a rare genetic disorder did not show significant benefit in a late-stage trial. Shares of the ...
Automated insulin delivery systems — a continuous glucose monitor, insulin pump, and algorithm — enable athletes to manage ...
Inhaled insulin shows safety and high treatment satisfaction in youth with type 1 diabetes over 26 weeks but does not meet ...
The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose readings.
Econostrum on MSN
Major recall of FreeStyle Libre devices: How this could impact your diabetes treatment
The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the ...
AUSTIN, Texas and TOKYO, Nov. 24, 2025 /PRNewswire/ --According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 ...
More than 537 million people worldwide live with diabetes today, and by 2030 this number is expected to surpass 640 million, creating urgent demand for safer, more accurate insulin administration ...
SYRACUSE, N.Y. — November is National Diabetes Awareness Month, highlighting a condition that affects 830 million people worldwide, including over 38 million Americans. Diabetes is categorized into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback